Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Nov 16, 2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today's announcement by Merit Medical Systems, Inc. that it...
-
Nov 2, 2017
Click on the links below to view results for the 2017 fourth fiscal quarter and full year: View document online PDF file of BD 2017 fourth fiscal quarter and full year results About BD BD is one...
-
Oct 26, 2017
Mississauga, Ontario, Oct. 26, 2017 – In recognition of Canadian Patient Safety Week (CPSW), occurring Oct. 30 – Nov.3, BD (Becton, Dickinson and Company), a leading global medical technology...
-
Oct 25, 2017Company Also Celebrates 50 Years of Cannula Production in Columbus
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined today by Gov. Pete Ricketts and other state and local leaders to break ground on a $60...
-
Sep 28, 2017
Mississauga, Ontario and Hamilton, Ontario - September 28, 2017 – BD (Becton, Dickinson and Company), a leading global medical technology company and the Canadian Society for Medical Laboratory...
-
Sep 26, 2017Fully-automated BD Phoenix(TM) CPO detect test helps detect dangerous pathogens
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch(1) of the first automated phenotypic test to detect and classify...
-
Sep 20, 2017New Molecular Assays Will be for Use on the BD MAX(TM) System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Euroclone (Euroclone Diagnostica Srl) today announced a development and global distribution...
-
Sep 19, 2017BD Ultra-Fine(TM) Micro 6mm Pen Needles Now Available
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the introduction of the BD Ultra-Fine(TM) micro pen needle 6mm x 32G for use with...
-
Sep 12, 2017BD Rhapsody(TM) single cell analysis system launches for gene expression profiling, plans to expand for protein analysis
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of BD Rhapsody, a platform for single cell analysis with the ability to...
-
Aug 28, 2017
SAN DIEGO, Aug. 28, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, Direct Relief and the National Association of Community Health Centers...
-
Aug 14, 2017
FRANKLIN LAKES, N.J., August 14, 2017 – BD (Becton, Dickinson and Company), a leading global medical technology company, has obtained 510(k) clearance from the U.S. Food and Drug Administration...
-
Aug 3, 2017
Click on the links below to view results for 2017 Third Fiscal Quarter: View Document Online PDF File of BD 2017 Third Fiscal Quarter Results About BD BD is one of the largest global medical...
-
Jul 19, 2017BD FACSLyric(TM) Flow Cytometer System with BD Multitest(TM) Assays Offers Reliability and Consistency
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)...
-
Jul 18, 2017New BD Kiestra(TM) Urine Culture App1 Drives Increased Lab Efficiency and Impacts Patient Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new technology that can automatically report and release negative urine cultures. Every...
-
Jun 20, 2017New Micro-Laparoscopic Instruments Offer Surgeons Less Invasive Option for Patients
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its new line of Snowden-Pencer((TM)) 3.0mm laparoscopic ergonomic take-apart...
-
Jun 13, 2017Leaders in flow cytometry tools collaborate to deliver cloud data management capabilities and streamline experimental execution
ASHLAND, Ore and FRANKLIN LAKES, N.J., June 13, 2017 ─ FlowJo, LLC, a life science informatics and data analysis company with 20 years of experience in software for analyzing single-cell data,...
-
Jun 6, 2017
FRANKLIN LAKES, N.J., June 6, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2016 Sustainability Report. BD’s...
-
Jun 5, 2017Extends BD MAX(TM) Enteric Panel Portfolio with latest Molecular Test that Targets Infectious Diarrhea
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its newly developed molecular test for detecting harmful intestinal bacteria...
-
May 15, 2017
Franklin Lakes, NJ (May 15, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming...
-
May 9, 2017BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room SettingNew Collaboration Aims to Provide Greater Visibility into Surgical Tracking and Loaner Tray Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and UniteOR, Inc., announced today the integration between BD's IMPRESS(TM) instrument management system...
-
May 7, 2017
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it has commenced registered offerings of $2.25 billion of common stock, par value $1.00 per share, and $2.25 billion of...
-
May 7, 2017
FRANKLIN LAKES, N.J., May 7, 2017 - BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it has commenced registered offerings of $2.25 billion of common stock, par value $1.00 per...
-
May 5, 2017
FRANKLIN LAKES, N.J., May 5, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that, in connection with BD's previously announced acquisition of C. R. Bard, Inc. ("Bard"), BD...
-
May 2, 2017
Click on the links below to view results for 2017 Second Fiscal Quarter: View Document Online PDF File of BD 2017 Second Fiscal Quarter Results About BD BD is one of the largest global medical...
-
May 2, 2017New Plastic Molding Manufacturing Center of Excellence Coming to Columbus-East Plant
COLUMBUS, Neb., May 2, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it will invest $60 million to upgrade its Columbus-East...
-
Apr 27, 2017Mass spectrometry identification solution may help hospitals manage antimicrobial resistance more effectively
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global distribution of a complete portfolio of products for mass spectrometry that...
-
Apr 26, 2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has non-exclusively licensed its patented stochastic labelling technology to...
-
Apr 23, 2017Will Create Highly Differentiated Medical Technology Company Focused on Delivering Innovative Healthcare Solutions to Improve Clinical and Economic Outcomes Will Build on BD’s Leadership Position in Medication Management and Infection Prevention; Will Increase Opportunities in Innovative Fast-Growing Clinical Areas Financially Compelling Transaction; Immediately Accretive and Expected to Generate High Single-Digit Accretion to Adjusted EPS in Fiscal Year 2019 Tom Polen Named BD President
FRANKLIN LAKES, NJ and MURRAY HILL, NJ (April 23, 2017) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and C. R. Bard, Inc. (NYSE: BCR), a medical...
-
Apr 23, 2017
FRANKLIN LAKES, N.J., April 23, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the appointment of Tom Polen, 43, as president...
-
Apr 6, 2017BD FACSVia(TM) System for Clinical Simplicity in Cell Analysis and Enumeration
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a...
-
Apr 6, 2017
FRANKLIN LAKES, N.J., April 6, 2017 – BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2017 earnings conference call...
-
Apr 4, 2017Expands Infusion Portfolio for Ambulatory, Home Care and Specialty Applications
FRANKLIN LAKES, N.J., April 4, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of...
-
Apr 3, 2017Visit booth #1115 to learn about the BD program focused on improving education, process and efficiency to impact patient safety
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its quality improvement program, BD "Power in Prevention" at the Association of...
-
Mar 28, 2017
WASHINGTON, March 28, 2017 – From the Mary’s Center in Washington, D.C., today BD (Becton, Dickinson and Company) (NYSE: BDX), in conjunction with Direct Relief and the National Association of...
-
Mar 22, 2017BD Showcases Solutions and Technologies to Improve Patient Safety Across the Continuum of Care at #EAHP2017
CANNES, March 22, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medication technology company, announced today the availability of its new IV Medication Safety Solution,...
-
Mar 1, 2017BD Awarded $100 Million Contract for Enterprise-Wide Automated Medication Dispensing Across 115 Military Health Facilities
FRANKLIN LAKES, N.J., MARCH 1, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it was awarded a contract worth up to $100...
-
Feb 22, 2017Health care providers and laboratories may be better equipped to test and treat patients during the flu season
Effective Feb. 13, 2017, the Food and Drug Administration (FDA) has reclassified antigen based rapid influenza virus antigen detection systems (RIDTs) intended to detect influenza virus directly...
-
Feb 21, 2017BD Helping Build Healthy Communities(TM) Partnership Awarded for Helping Improve Care for Underserved Areas
A partnership among BD (Becton Dickinson and Company) (NYSE: BDX), Direct Relief and the National Association of Community Health Centers was selected as one of three winners for the Healthy10...
-
Feb 20, 2017BD Showcases its Leadership in Enterprise-wide Medication Management at #HIMSS2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will demonstrate its approach to a synchronized medication management technology platform aimed to help...
-
Feb 17, 2017
Franklin Lakes, NJ (February 17, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming...
-
Feb 16, 2017BD Aims to Improve the Management of Controlled Substances for Acute Care Facilities through Industry Alliance
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new alliance dedicated to help address the rising opioid crisis in acute care...
-
Feb 13, 2017Legacy Experience In Cell Sorting And Enrichment Combined With New Single- Cell And Library Prep Technology Offers Ideal Resolution Of Individual Cells At The Lowest Cost-Per-Answer
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an early access program for the BD Resolve(TM) Single-Cell Gene Expression platform...
-
Feb 2, 2017-- As reported, revenues of $2.922 billion decreased 2.1 percent, which reflects the divestiture of the Respiratory Solutions business.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.922 billion for the first fiscal quarter ended December 31,...
-
Feb 2, 2017Click on the links below to view results for 2017 First Fiscal Quarter:
View Document Online PDF File of BD 2017 First Fiscal Quarter Results About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by...
-
Jan 26, 2017BD Launches New Initiative to Drive Simpler, Safer and Cost-Effective Medication Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its new BD Institute for Medication Management Excellence, developed to...
-
Jan 23, 2017Indication for Congestive Heart Failure on Display at the 2017 Society of Thoracic Surgeons (STS) Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its PleurX(TM) catheter system received U.S. Food and Drug Administration (FDA) 510(k)...
-
Jan 23, 2017
Franklin Lakes, NJ (January 23, 2017) - The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 73 cents per common share, payable on March...
-
Jan 20, 2017New Framework Provides Recommendations for Optimizing Diagnostic Solutions to Combat AMR
Davos-Klosters, Switzerland - AdvaMedDx, the association representing manufacturers of diagnostic tests to promote wellness, improve patient outcomes, and advance public health, today announced a...
-
Jan 18, 2017
Franklin Lakes, NJ (January 18, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting...
-
Jan 17, 2017Precise WTA Reagents Provide Accurate, Simple Quantification of Genetic Information in Individual Cells
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial availability of its new kits that provide an easier method to identify...